Assignee
SHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD
CN·5 granted patents·0 citations·filing 2015–2021
Top patents by PatentIndex Score
5 records- 0151US11192882B2Crystal form of small molecule immune compound, preparation method thereof and pharmaceutical composition containing the sameSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2019·Granted Dec 7, 2021·0 cites·8 claims
- 0248US12391706B2Multi-target tyrosine kinase inhibitorSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2021·Granted Aug 19, 2025·0 cites·13 claims
- 0345US10668069B2Pharmaceutical composition comprising neptinib or salt thereof and method for controlling impurity thereofSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2017·Granted Jun 2, 2020·0 cites·7 claims
- 0445US9957237B2Crystal form of neptinib di-p-methylbenzenesulfonate, preparation method thereof, and pharmaceutical composition containing sameSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2015·Granted May 1, 2018·0 cites·8 claims
- 0541US10640492B2Tubulin inhibitorSHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD·Filed 2017·Granted May 5, 2020·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when SHENZHEN NEPTUNUS PHARMACEUTICAL RES INSTITUTE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →